Andrew Scott is currently the National Sales Manager and Market Access Manager at CSL, focusing on rare bleeding disorders and gene therapy in the UK and Ireland. Previously, Andrew held positions such as Integrated Healthcare Specialist at AstraZeneca, Senior Territory Manager at Johnson & Johnson, and Key Account Manager at Baxter International Inc. From 2021 to 2024, Andrew served as UK Commercial Manager at Britannia Pharmaceuticals Ltd. Andrew's extensive experience in the pharmaceutical industry spans over a decade, with a proven track record in sales and market access.
This person is not in the org chart
This person is not in any teams
This person is not in any offices